Wilmington Group Plc
05 December 2007
WILMINGTON GROUP PLC
Announcement to the London Stock Exchange
This notification is made in accordance with DTR 3.1.4 and DTR 3.1.4(1)(b).
On 5 December 2007, the following awards over ordinary shares in the Company
were made under the Wilmington Group plc 2007 Performance Share Plan (the
'Plan') to Directors of the Company and other Persons Discharging Managerial
Responsibility ('PDMRs'):
Name of Director/PDMR Number of shares under the Award
Charles Brady (Chief Executive) 189,393
Basil Brookes (Finance Director) 128,787
Rory Conwell (Director) 63,131
Neil Smith (PDMR) 56,060
Michael Harrington (PDMR) 53,030
Stephen Broome(PDMR) 50,000
No consideration was paid for the grant of the award which is structured as a
conditional award.
The vesting of an award is subject to the satisfaction of performance conditions
set by the Remuneration Committee of the Company. The award will normally vest
on the later of the third anniversary of grant and the determination of the
performance conditions.
Ahmed Zahedieh
Company Secretary
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.